[Ip-health] Survey: US Health Agency Should Use Patent Rights To Keep Drugs Affordable

George Carter fiar at verizon.net
Wed Sep 4 18:00:33 PDT 2013


Well, and here's another earlier one - 
http://www.cptech.org/pharm/crada2.html 

but with the revolving door between NIH and industry, any sincere application of a CRADA would never happen. As but one example:
https://www.commondreams.org/headlines03/1207-03.htm

(Bill Moyers also had a discussion about this focused on Congress and industry recently.)

Then there's this:
http://californiastemcellreport.blogspot.com/2005/10/text-of-legislative-staff-report-on-ip.html 
"Reasonable pricing requirement. The state could adopt a policy similar to that adopted by the National Institutes of Health (NIH) in 1989 requiring that there be a reasonable relationship between the pricing of a licensed product, the public investment in that product, and the health and safety needs of the public. As mentioned above, NIH applied this policy to licenses to inventions developed under its Cooperative Research and Development Agreement (CRADA) program but discarded it in 1995 on the grounds that it was impeding commercialization of research findings."

Yeah, right.

And:
http://www.scribd.com/doc/54116297/Goozner-The-800-Million-Pill-The-Truth-Behind-the-Cost-of-New-Drugs-2004 

Which leads to stories like:
http://www.thebody.com/content/art33449.html 

When the government is bought, run and dependent upon the largesse and future careers of the industry's they're supposed to regulate and oversee...well, the noble notion of a CRADA is a joke.

The questions I posed, of course, are ridiculous because the United States government will only serve their corporate masters. The niceties of the details become lost in the haze of blood of the millions dying, the only metric that matters and to which that government and Pharma are utterly indifferent. But some of us will remember and maybe one day there will be justice for their willful and intentional acts of economic genocide.
George M. Carter






More information about the Ip-health mailing list